
News|Articles|October 1, 2005
PREAMI trial
The ACE inhibitor perindopril significantly reduced left ventricular remodeling in a well-treated population of older patients with acute myocardial infarction (MI) and preserved ejection fraction, said Roberto Ferrari, MD, PhD, lead investigator of the Perindopril Remodeling in Elderly with Acute Myocardial Infarction (PREAMI).
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New therapies on the way to lower Lp(a), a cardiovascular risk factor
2
A conversation with Elizabeth Mitchell, president and CEO of PBGH
3
PCMA names David Marin as new president and CEO
4
IBX names Jefferson Health, Penn Medicine and Temple Health as 2026 Clinical Care Innovation Grant recipients
5






















































